07:19 AM EDT, 08/27/2024 (MT Newswires) -- Eli Lilly ( LLY ) said Tuesday that single-dose vials of its Zepbound treatment for obesity in adults are now available for self-paying patients with on-label prescriptions, expanding access to the product.

The vials come in 2.5-milligram and 5mg doses and are available through a new self-pay pharmacy division of the company's LillyDirect, according to the company.

Price: 940.31, Change: -10.22, Percent Change: -1.08